13.07.2015 Views

Official Proceedings - AIUM

Official Proceedings - AIUM

Official Proceedings - AIUM

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

American Institute of Ultrasound in Medicine <strong>Proceedings</strong> J Ultrasound Med 32(suppl):S1–S134, 2013Fisher test was used to assess the significance of the morphologic changesbetween the exposed and nonexposed groups.Results—Twenty hemangiomas in 18 patients (66% female/34% male; age range, 1 month–1 year) were studied. Nine patients were in theexposed group and 9 in the nonexposed group. Single lesions: 89%; 2 lesions:11%. Location: 75% head and neck (20% cheek, 20% lips, 13.6% nose, 13.3%scalp, 13.3% temple, 6.6% eyelid, 6.6% neck, 6.6% submandibular), 15%trunk, 5% upper extremity, 5%lower extremity. The exposed group showed asignificant decrease (P < .05) of the volume (P = .033) and transverse axis (P= .033) of hemangiomas in comparison with the nonexposed group. The restof the P values were thickness, P = .057; longitudinal axis, P = .37; thicknessof vessels, P = 1; and peak systolic velocity, P = 1.Conclusions—Sonography can register the changes in the morphologyof cutaneous hemangiomas of infancy that are medically treated.Propanolol can significantly reduce the volume and transverse axis of hemangiomasof infancy in comparison with the nontreated group of patients.1537671 Natural History of Fetal Pyelectasis and Risk of InfantUropathyEmily Neri, 1 * Jean Goodman, 1,3 Jennifer Peck 2 1 Obstetricsand Gynecology, 2 School of Public Health, University of OklahomaHealth Sciences Center, Oklahoma City, Oklahoma USA;3Obstetrics and Gynecology, Loyola University Medical Center,Maywood, Illinois USAObjectives—The objectives of this study were to (1) determinethe rate of resolution of fetal pyelectasis identified in the second trimesterprior to delivery and (2) determine the predictive value of varied degreesof pyelectasis identified in the antenatal period and infant uropathy.Methods—A retrospective study was designed, with review ofall prenatal ultrasounds with a diagnosis of second-trimester pyelectasis inour established database between May 2010 and January 2011. Per ourroutine for this diagnosis, repeat ultrasounds in the third trimester wereperformed and also reviewed. Maternal and newborn records from ourelectronic medical record and infant renal ultrasound records were examined.Exclusion criteria were chromosome abnormalities, fetal anomalies,multiple pregnancies, and delivery not at our facility. The incidences of pyelectasisin the second trimester, persistence in the third trimester, and persistenceafter delivery were defined. Varied pyelectasis measure cut pointswere determined to assess the utility of pyelectasis as a screening test forpostnatal uropathy.Results—During the 9-month period, there were 119 secondtrimesterultrasounds with isolated pyelectasis identified with subsequentthird-trimester ultrasound and delivery at our facility. The incidence of pyelectasiswas 1%, with a mean anteroposterior renal pelvis diameter of 5.2mm in the second trimester and 6.0 mm in the third trimester (range, 4–10mm). Twelve percent of second-trimester pyelectasis resolved by the thirdtrimester, and 45% resolved by delivery. Of third-trimester follow-up scans,all those who resolved by delivery had measured diameters

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!